List of Tables
Table 1. Global Mouse Model for Drug Screening and Evaluation Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Mouse Model for Drug Screening and Evaluation Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Mouse Model for Drug Screening and Evaluation Market Competitive Situation by Manufacturers in 2023
Table 4. Global Mouse Model for Drug Screening and Evaluation Sales (Unit) of Key Manufacturers (2019-2024)
Table 5. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Mouse Model for Drug Screening and Evaluation Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Mouse Model for Drug Screening and Evaluation Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Mouse Model for Drug Screening and Evaluation Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Mouse Model for Drug Screening and Evaluation, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Mouse Model for Drug Screening and Evaluation, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mouse Model for Drug Screening and Evaluation, Product Type & Application
Table 12. Global Key Manufacturers of Mouse Model for Drug Screening and Evaluation, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mouse Model for Drug Screening and Evaluation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mouse Model for Drug Screening and Evaluation as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mouse Model for Drug Screening and Evaluation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Mouse Model for Drug Screening and Evaluation Sales by Region (2019-2024) & (Unit)
Table 18. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Region (2019-2024)
Table 19. Global Mouse Model for Drug Screening and Evaluation Sales by Region (2025-2030) & (Unit)
Table 20. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Region (2025-2030)
Table 21. Global Mouse Model for Drug Screening and Evaluation Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Region (2019-2024)
Table 23. Global Mouse Model for Drug Screening and Evaluation Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Region (2025-2030)
Table 25. North America Mouse Model for Drug Screening and Evaluation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Mouse Model for Drug Screening and Evaluation Sales by Country (2019-2024) & (Unit)
Table 27. North America Mouse Model for Drug Screening and Evaluation Sales by Country (2025-2030) & (Unit)
Table 28. North America Mouse Model for Drug Screening and Evaluation Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Mouse Model for Drug Screening and Evaluation Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Mouse Model for Drug Screening and Evaluation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Mouse Model for Drug Screening and Evaluation Sales by Country (2019-2024) & (Unit)
Table 32. Europe Mouse Model for Drug Screening and Evaluation Sales by Country (2025-2030) & (Unit)
Table 33. Europe Mouse Model for Drug Screening and Evaluation Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Mouse Model for Drug Screening and Evaluation Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Mouse Model for Drug Screening and Evaluation Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Mouse Model for Drug Screening and Evaluation Sales by Region (2019-2024) & (Unit)
Table 37. Asia Pacific Mouse Model for Drug Screening and Evaluation Sales by Region (2025-2030) & (Unit)
Table 38. Asia Pacific Mouse Model for Drug Screening and Evaluation Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Mouse Model for Drug Screening and Evaluation Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Mouse Model for Drug Screening and Evaluation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Mouse Model for Drug Screening and Evaluation Sales by Country (2019-2024) & (Unit)
Table 42. Latin America Mouse Model for Drug Screening and Evaluation Sales by Country (2025-2030) & (Unit)
Table 43. Latin America Mouse Model for Drug Screening and Evaluation Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Mouse Model for Drug Screening and Evaluation Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Mouse Model for Drug Screening and Evaluation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Mouse Model for Drug Screening and Evaluation Sales by Country (2019-2024) & (Unit)
Table 47. Middle East and Africa Mouse Model for Drug Screening and Evaluation Sales by Country (2025-2030) & (Unit)
Table 48. Middle East and Africa Mouse Model for Drug Screening and Evaluation Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Mouse Model for Drug Screening and Evaluation Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Mouse Model for Drug Screening and Evaluation Sales (Unit) by Type (2019-2024)
Table 51. Global Mouse Model for Drug Screening and Evaluation Sales (Unit) by Type (2025-2030)
Table 52. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Type (2019-2024)
Table 53. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Type (2025-2030)
Table 54. Global Mouse Model for Drug Screening and Evaluation Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Mouse Model for Drug Screening and Evaluation Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Type (2019-2024)
Table 57. Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Type (2025-2030)
Table 58. Global Mouse Model for Drug Screening and Evaluation Price (USD/Unit) by Type (2019-2024)
Table 59. Global Mouse Model for Drug Screening and Evaluation Price (USD/Unit) by Type (2025-2030)
Table 60. Global Mouse Model for Drug Screening and Evaluation Sales (Unit) by Application (2019-2024)
Table 61. Global Mouse Model for Drug Screening and Evaluation Sales (Unit) by Application (2025-2030)
Table 62. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Application (2019-2024)
Table 63. Global Mouse Model for Drug Screening and Evaluation Sales Market Share by Application (2025-2030)
Table 64. Global Mouse Model for Drug Screening and Evaluation Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Mouse Model for Drug Screening and Evaluation Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Application (2019-2024)
Table 67. Global Mouse Model for Drug Screening and Evaluation Revenue Market Share by Application (2025-2030)
Table 68. Global Mouse Model for Drug Screening and Evaluation Price (USD/Unit) by Application (2019-2024)
Table 69. Global Mouse Model for Drug Screening and Evaluation Price (USD/Unit) by Application (2025-2030)
Table 70. ingenious targeting laboratory Company Information
Table 71. ingenious targeting laboratory Description and Business Overview
Table 72. ingenious targeting laboratory Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. ingenious targeting laboratory Mouse Model for Drug Screening and Evaluation Product
Table 74. ingenious targeting laboratory Recent Developments/Updates
Table 75. The Jackson Laboratory Company Information
Table 76. The Jackson Laboratory Description and Business Overview
Table 77. The Jackson Laboratory Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. The Jackson Laboratory Mouse Model for Drug Screening and Evaluation Product
Table 79. The Jackson Laboratory Recent Developments/Updates
Table 80. Charles River Company Information
Table 81. Charles River Description and Business Overview
Table 82. Charles River Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Charles River Mouse Model for Drug Screening and Evaluation Product
Table 84. Charles River Recent Developments/Updates
Table 85. Taconic Biosciences Company Information
Table 86. Taconic Biosciences Description and Business Overview
Table 87. Taconic Biosciences Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Taconic Biosciences Mouse Model for Drug Screening and Evaluation Product
Table 89. Taconic Biosciences Recent Developments/Updates
Table 90. Cavens Company Information
Table 91. Cavens Description and Business Overview
Table 92. Cavens Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Cavens Mouse Model for Drug Screening and Evaluation Product
Table 94. Cavens Recent Developments/Updates
Table 95. Beijing Vitalstar Biotechnology Company Information
Table 96. Beijing Vitalstar Biotechnology Description and Business Overview
Table 97. Beijing Vitalstar Biotechnology Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Beijing Vitalstar Biotechnology Mouse Model for Drug Screening and Evaluation Product
Table 99. Beijing Vitalstar Biotechnology Recent Developments/Updates
Table 100. Model Organisms Center Company Information
Table 101. Model Organisms Center Description and Business Overview
Table 102. Model Organisms Center Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Model Organisms Center Mouse Model for Drug Screening and Evaluation Product
Table 104. Model Organisms Center Recent Developments/Updates
Table 105. GENET-MED Company Information
Table 106. GENET-MED Description and Business Overview
Table 107. GENET-MED Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. GENET-MED Mouse Model for Drug Screening and Evaluation Product
Table 109. GENET-MED Recent Developments/Updates
Table 110. Cyagen Company Information
Table 111. Cyagen Description and Business Overview
Table 112. Cyagen Mouse Model for Drug Screening and Evaluation Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Cyagen Mouse Model for Drug Screening and Evaluation Product
Table 114. Cyagen Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Mouse Model for Drug Screening and Evaluation Distributors List
Table 118. Mouse Model for Drug Screening and Evaluation Customers List
Table 119. Mouse Model for Drug Screening and Evaluation Market Trends
Table 120. Mouse Model for Drug Screening and Evaluation Market Drivers
Table 121. Mouse Model for Drug Screening and Evaluation Market Challenges
Table 122. Mouse Model for Drug Screening and Evaluation Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mouse Model for Drug Screening and Evaluation
Figure 2. Global Mouse Model for Drug Screening and Evaluation Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Mouse Model for Drug Screening and Evaluation Market Share by Type: 2023 & 2030
Figure 4. Tumor Model Product Picture
Figure 5. Nervous System Model Product Picture
Figure 6. Immunodeficiency Product Picture
Figure 7. Metabolic and Cardiovascular Disease Model Product Picture
Figure 8. Digestive System Model Product Picture
Figure 9. Others Product Picture
Figure 10. Global Mouse Model for Drug Screening and Evaluation Market Value by Application (2024-2030) & (US$ Million)
Figure 11. Global Mouse Model for Drug Screening and Evaluation Market Share by Application: 2023 & 2030
Figure 12. Research Laboratories
Figure 13. Pharmaceutical Companies
Figure 14. Other
Figure 15. Global Mouse Model for Drug Screening and Evaluation Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Mouse Model for Drug Screening and Evaluation Market Size (2019-2030) & (US$ Million)
Figure 17. Global Mouse Model for Drug Screening and Evaluation Sales (2019-2030) & (Unit)
Figure 18. Global Mouse Model for Drug Screening and Evaluation Average Price (USD/Unit) & (2019-2030)
Figure 19. Mouse Model for Drug Screening and Evaluation Report Years Considered
Figure 20. Mouse Model for Drug Screening and Evaluation Sales Share by Manufacturers in 2023
Figure 21. Global Mouse Model for Drug Screening and Evaluation Revenue Share by Manufacturers in 2023
Figure 22. Global 5 and 10 Largest Mouse Model for Drug Screening and Evaluation Players: Market Share by Revenue in Mouse Model for Drug Screening and Evaluation in 2023
Figure 23. Mouse Model for Drug Screening and Evaluation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 24. Global Mouse Model for Drug Screening and Evaluation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Mouse Model for Drug Screening and Evaluation Sales Market Share by Country (2019-2030)
Figure 26. North America Mouse Model for Drug Screening and Evaluation Revenue Market Share by Country (2019-2030)
Figure 27. United States Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Mouse Model for Drug Screening and Evaluation Sales Market Share by Country (2019-2030)
Figure 30. Europe Mouse Model for Drug Screening and Evaluation Revenue Market Share by Country (2019-2030)
Figure 31. Germany Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Mouse Model for Drug Screening and Evaluation Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Mouse Model for Drug Screening and Evaluation Revenue Market Share by Region (2019-2030)
Figure 38. China Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Mouse Model for Drug Screening and Evaluation Sales Market Share by Country (2019-2030)
Figure 46. Mexico Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East and Africa Mouse Model for Drug Screening and Evaluation Sales Market Share by Country (2019-2030)
Figure 51. Middle East and Africa Mouse Model for Drug Screening and Evaluation Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Mouse Model for Drug Screening and Evaluation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Mouse Model for Drug Screening and Evaluation by Type (2019-2030)
Figure 56. Global Revenue Market Share of Mouse Model for Drug Screening and Evaluation by Type (2019-2030)
Figure 57. Global Mouse Model for Drug Screening and Evaluation Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Mouse Model for Drug Screening and Evaluation by Application (2019-2030)
Figure 59. Global Revenue Market Share of Mouse Model for Drug Screening and Evaluation by Application (2019-2030)
Figure 60. Global Mouse Model for Drug Screening and Evaluation Price (USD/Unit) by Application (2019-2030)
Figure 61. Mouse Model for Drug Screening and Evaluation Value Chain
Figure 62. Mouse Model for Drug Screening and Evaluation Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
